Skip to main content
. 2022 Feb 21;10(2):506. doi: 10.3390/biomedicines10020506
A-scan A-mode ultrasonography
ABCB5 ATP-binding cassette sub-family B member 5
ADC Apparent diffusion coefficient
AJCC American Joint committee on cancer
AKT Protein kinase B
ALIX Programmed cell death 6-interacting protein
B-scan B-mode ultrasonography
BAP1 BRCA1-associated protein
CD Cluster of differentiation
cfDNA Cell free DNA
CM Cutaneous melanoma
CNV Copy number variation
CT Computed tomography
CTC Circulating tumor cell
ctDNA Circulating tumor DNA
CTDSPL CTD small phosphatase like
CTGF Connective tissue growth factor
CTLA-1 cytotoxic T-lymphocyte-associated antigen 4
CYSLTR2 Cysteinyl Leukotriene Receptor 2
DCE-MRI Dynamic contrast-enhanced magnetic resonance imaging
ddPCR Droplet digital PCR
DJ-1 Parkinson disease protein 7
DNA Deoxyribonucleic acid
dsDNA Double stranded DNA
DW Diffusion-weighted
ECM1 Extracellular matrix protein 1
EDI Enhanced depth imaging
EIF1AX Eukaryotic translation initiation factor 1A, X-linked
EMT Epithelial to mesenchymal transition
EpCAM Epithelial cell adhesion molecule
EV Extracellular vesicles
FDA Food and drug administration
FDG Fluorodeoxyglucose
FFPE Formalin-fixed paraffin-embedded
FISH Fluorescence in situ hybridization
FNAB Fine needle aspiration biopsy
fSRT Fractionated stereotactic radiotherapy
GNA11 G-protein α subunit 11
GNAQ G-protein α subunit Q
Gp100 Glycoprotein 100
HLA Human leukocyte antigen
HOXA11 Homeobox 11
HTRA1 Serine proteoase HTRA1
IFN-γ Interferon gamma
IGFBP1 Insulin-like growth factor-binding protein 7
IL Interleukin
LAMA1 Laminin subunit alpha-1
LAMP1 Lysosome-associated membrane glycoprotein 1
LDH Lactate dehydrogenase
MACS Magnetic activated cell sorting
MAGED1 Melanoma-associated antigen D1
MAGED2 Melanoma-associated antigen D2
MCAM Melanoma cell adhesion molecule
MCSP Melanoma-associated chondroitin sulfate proteoglycan
MIA Melanoma inhibitory activity
miR MicroRNA
miRNA MicroRNA
MITF Microphthalmia-associated transcription factor
MLANA Melanoma antigen recognized by T-cells 1
MRI Magnetic resonance imaging
mRNA Messenger RNA
NCAM Neural cell adhesion molecules
NDFIP1 Nedd4-family interactive protein 1
NHS National Health Service
NRP2 Neuropilin-2
OCT Optical coherence tomography
OS Overall survival
OXPHOS Oxidative phosphorylation
PAM Peptidyl-glycine alpha-amidating monooxygenase
PBT proton beam therapy
PD-1 Programmed cell death protein 1
PDHB Pyruvate dehydrogenase E1 subunit Beta
PDT photodynamic therapy
PET/CT Positron emission tomography/computed tomography
PFS Progression free survival
PI3K Phosphoinositide 3-kinase
PLCB4 Phospholipase C beta 4
PTEN Phosphatase and Tensin homolog
qNPA Quantitative nuclease protection assay
RNA Ribonucleic acid
ROMS Rotterdam Ocular Melanoma Study group
RT-PCR Reverse transcription polymerase chain reaction
RT2-array Qiagen RT2 miRNA PCR array (brain cancer panel)
S-100β S100 calcium binding protein beta
SDHA Succinate dehydrogenase
SERPINE1 Plasminogen activator inhibitor, type 1
SF3B1 Splicing factor 3B unit 1
SMART-seq Switching Mechanism at 5′ end of RNA Template
sWGS Shallow whole genome sequencing
THBS2 Thrombospondin 2
TLDA Taqman low density array
TOP2A DNA topoisomerase IIa
TTT Transpupillary thermotherapy
UK United Kingdom
ULBP2 UL16-binding protein 2
UM Uveal melanoma
US Ultrasonography
V Protein V homolog
VA Visual acuity
VEGF Vascular endothelial growth factor
VGF VGF nerve growth factor inducible
VH Vitreous humor
γGT Gamma glutamyl transferase